← FDA Drug Approvals (Drugs@FDA)

LANSOPRAZOLE

ANDA · Abbreviated New Drug Application (Generic) · Sponsor: XIROMED · Approved 2016-07-25

Drug application

FDA Application #

ANDA203203

Application type

Abbreviated New Drug Application (Generic)

Brand name

LANSOPRAZOLE

Generic name

LANSOPRAZOLE

Active ingredients

LANSOPRAZOLE

Dosage form

CAPSULE, DELAYED REL PELLETS

Route

ORAL

Marketing status

Prescription

Sponsor

XIROMED

Manufacturer

Xiromed LLC

First approval

2016-07-25

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown